Mobile Menu

Search Videos

Genomics for better health
Featuring speakers from GSK and the University of Oxford
Rare Disease as an Emerging Field of Medicine
Marshall Summar, Director, Rare Disease Institute, Children’s National Health System
Molecular diagnostics and the NHSE Long Term Plan for Cancer
Peter Johnson, National Clinical Director for Cancer, NHS England
How Genomics is Changing the Shape of Healthcare: England’s NHS Continues its Momentum
Dame Sue Hill, Chief Scientific Officer, NHS England and NHS Improvement
Applications of RNA-seq for infectious disease research
Jose Afonso Guerra-Assuncao, Research Associate, UCL
The Future of Genomics: Health and Beyond
Sir Patrick Vallance, Government Chief Scientific Adviser, UK Government
Mapping immune cells in tissues using single cell and spatial genomics
Sarah Teichmann, Cellular Genetics Programme Head, Wellcome Sanger Institute
Drugging the cancer genome: progress, opportunities and challenges in personalised medicine
Paul Workman, Professor of Pharmacology and Therapeutics, Institute of Cancer Research
Translating germline cancer genomics into precision prevention of cancer
Clare Turnbull, Professor of Translational Cancer Genetics, Institute of Cancer Research
The Forefront of Genomics: Opportunities, Challenges, and Imperatives
Eric Green, Director, National Human Genome Research Institute (NHGRI)
Cancer evolution, immune evasion and metastasis
Charles Swanton, Senior Group Leader, Crick Institute
Advancing Genomic Medicine Through Global Collaboration and Data Sharing
Heidi Rehm, Chief Genomics Officer, Centre for Genomic Medicine and Co-Director, Medical and Population Genetics, Massachesetts General Hospital and Broad Institute
Spatial and temporal RNA-sequencing
Sam Rodriques, Group Leader, Francis Crick Institute
Combining long and short read sequencing
Andrew Beggs, Mike Hubank and Matt Loose
All of Us Research Program: Advancing Precision Health for All Populations
Stephanie Devaney, Chief Operating Officer, All of Us Research Programme,National Institutes of Health (NIH)
Liquid biopsy: From discovery to clinical implementation
Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf
UK Biobank: Going Beyond Genomics in 2022
Mark Effingham, Deputy Chief Executive Officer, UK Biobank